text: FDA Issues  #39;Approvable Letter #39; for Certican BASEL, Switzerland, August 30 /PRNewswire/ -- Novartis Pharma AG has received an  quot;approvable quot; letter from the US Food and Drug Administration (FDA) for Certican (everolimus) in combination with Neoral (ciclosporin for microemulsion) for the prevention of 